HIV Antigen Incorporation within Adenovirus Hexon Hypervariable 2 for a Novel HIV Vaccine Approach

Strategies to overcome host immunity to adenovirus vectors in vaccine development

(2009) Erin E Thacker et al.   Expert Review of Vaccines

Adenovirus type 5 with modified hexons induces robust transgene-specific immune responses in mice with pre-existing immunity against adenovirus type 5

(2009) Shinya Abe et al.   JOURNAL OF GENE MEDICINE

Lac-regulated system for generating adenovirus 5 vaccine vectors expressing cytolytic human immunodeficiency virus 1 genes

(2009) Chunxia Zhao et al.   JOURNAL OF VIROLOGICAL METHODS

Broad Neutralization of Human Immunodeficiency Virus Type 1 (HIV-1) Elicited from Human Rhinoviruses That Display the HIV-1 gp41 ELDKWA Epitope

(2009) G. F. Arnold et al.   JOURNAL OF VIROLOGY

Comparison of Replication-Competent, First Generation, and Helper-Dependent Adenoviral Vaccines

(2009) Eric A. Weaver et al.   PLoS One

Effects of Shielding Adenoviral Vectors with Polyethylene Glycol (PEG) on Vector-specific and Vaccine-mediated Immune Responses

(2008) Eric A Weaver et al.   HUMAN GENE THERAPY

The failed HIV Merck vaccine study: a step back or a launching point for future vaccine development?

(2008) Rafick-Pierre Sekaly   JOURNAL OF EXPERIMENTAL MEDICINE

Immunization Against the Transgene but not the TetON Switch Reduces Expression From Gutless Adenoviral Vectors in the Brain

(2008) Weidong Xiong et al.   MOLECULAR THERAPY

Derivation of a triple mosaic adenovirus based on modification of the minor capsid protein IX

(2008) Yizhe Tang et al.   VIROLOGY

Optimization of Capsid-Incorporated Antigens For A Novel Adenovirus Vaccine Approach

(2008) Qiana L Matthews et al.   Virology Journal